reImagining drug development for rare diseases.


A world reImagined…

Odylia is a unique nonprofit biotech bringing life-changing treatments to people with rare genetic disorders, regardless of prevalence or commercial interest. We help groups navigate the complexity of bringing treatments from the lab to patients.

Rethinking drug development for rare disease

Can you imagine new treatments being developed hand-in-hand with patients, families, researchers, and companies? We build innovative partnerships and unique solutions that involve rare disease patients in the process of making new therapeutics.

Blind man walking a dog using a cane.

Learn how we are making a difference

Learn about the Odylia gene therapy pipeline

Gene Therapy Pipeline

Learn about Odylia's innovative partnerships

Brydge Solutions

Learn about our Odylia team

Our Origin Story

Learn about the impact Odylia is making

Case Studies

reImagine with us…

There is little commercial interest in these treatments due to the rare nature of the diseases. Odylia relies on contributions from nonprofit organizations, patient groups, corporate donors, and more to help advance our mission of bringing life-changing treatments to people with rare disease.